Clinical value of Epstein–Barr virus DNA levels in peripheral blood samples of Italian patients with Undifferentiated Carcinoma of Nasopharyngeal Type
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 233 (2) , 247-254
- https://doi.org/10.1016/j.canlet.2005.03.015
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategiesTrends in Microbiology, 2004
- Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal CarcinomaNew England Journal of Medicine, 2004
- Diagnostic value of serum EBV‐DNA quantification and antibody to viral capsid antigen in nasopharyngeal carcinoma patientsCancer Science, 2004
- Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapyCancer, 2004
- Nasopharyngeal carcinomasEuropean Journal Of Cancer, 2003
- Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated typeCancer, 2003
- Comparison of Quantitative Competitive PCR with LightCycler-Based PCR for Measuring Epstein-Barr Virus DNA Load in Clinical SpecimensJournal of Clinical Microbiology, 2002
- Nasopharyngeal cancer WHO type II-III: monoinstitutional retrospective analysis with standard and accelerated hyperfractionated radiation therapyOral Oncology, 2002
- Prognostic implication of pretreatment plasma/serum concentration of Epstein-Barr virus DNA in nasopharyngeal carcinomaBiomedicine & Pharmacotherapy, 2001
- Detection of Epstein-Barr Virus DNA in the Peripheral-Blood Cells of Patients With Nasopharyngeal Carcinoma: Relationship to Distant Metastasis and SurvivalJournal of Clinical Oncology, 2001